Home > Riviste > Giornale Italiano di Dermatologia e Venereologia > Fascicoli precedenti > Giornale Italiano di Dermatologia e Venereologia 2018 August;153(4) > Giornale Italiano di Dermatologia e Venereologia 2018 August;153(4):477-82

ULTIMO FASCICOLO
 

JOURNAL TOOLS

eTOC
Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Publication history
Estratti
Permessi
Per citare questo articolo

 

ORIGINAL ARTICLE   

Giornale Italiano di Dermatologia e Venereologia 2018 August;153(4):477-82

DOI: 10.23736/S0392-0488.16.05413-4

Copyright © 2016 EDIZIONI MINERVA MEDICA

lingua: Inglese

The role of irisin in the relationship between psoriasis and insulin resistance

Isil BULUR 1 , Hilal K. ERDOGAN 1, Evin KOCATÜRK 2, Zeynep N. SARACOGLU 1, Özkan ALATAŞ 2, Pınar YILDIZ 3, Muzaffer BILGIN 4

1 Department of Dermatology and Venereology, Faculty of Medicine, Eskişehir Osmangazi University, Eskişehir, Turkey; 2 Department of Biochemistry, Faculty of Medicine, Eskişehir Osmangazi University, Eskişehir, Turkey; 3 Department of Internal Medicine, Faculty of Medicine, Eskişehir Osmangazi University, Eskişehir, Turkey; 4 Department of Biostatistics, Faculty of Medicine, Eskişehir Osmangazi University, Eskişehir, Turkey


PDF


BACKGROUND: Irisin, a hormone like myokine, is identified to the relation with insulin resistance and metabolic syndrome recently. In the literature to date, there are no studies evaluating serum irisin levels in psoriasis patients. We aimed to elucidate the pathogenesis of insulin resistance in psoriasis patients by evaluating serum irisin levels and metabolic parameters associated with insulin resistance in patients with plaque-type psoriasis vulgaris.
METHODS: The study included 40 patients with moderate-to-severe chronic plaque-type psoriasis vulgaris and 37 healthy subjects. Body Mass Index (BMI) and waist circumference were measured, and serum irisin, fasting blood glucose (FBG), lipid profile, high-sensitivity CRP (hs-CRP) and insulin levels were assessed. To evaluate insulin resistance, the Homeostasis Model Assessment (HOMA-IR) and triglyceride/HDL (TG/HDL) ratio were used.
RESULTS: Serum irisin and HDL levels were significantly lower in patients than the control group (P<0.001, P=0.024). Within the patient group, there was a significant negative correlation between serum irisin and serum TG, LDL, and TG/HDL levels (P=0.041, P=0.022, P=0.025), and a positive correlation with HDL levels (P=0.036). The PASI scores and serum irisin levels were significantly positively correlated.
CONCLUSIONS: In conclusion, we observed that serum irisin levels were significantly lower in patients with psoriasis, and associated with serum lipid levels and disease activity in our study. These results can be interpreted that irisin is involved in the disease pathogenesis of patients with psoriasis in relation to metabolic dysregulation.


KEY WORDS: Insulin resistance - Hormones - Psoriasis - Triglycerides - Cholesterol, HDL

inizio pagina